Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic Global Holding SA, has received approval from the US health regulator for its generic Treprostinil injection used for the treatment of pulmonary arterial hypertension.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3p7XtDy
via IFTTT
0 comments:
Post a Comment